Jo K. Mohr

Jo K. Mohr is a Principal of BioAsset Advisors.  Jo has over 20 years of experience developing strategic growth plans for global OTC drug and Consumer Products companies and executing them through Licensing, M&A, and Strategic Alliances.

Jo works effectively with cross-functional input from Marketing, Medical/Clinical, Regulatory and Manufacturing to evaluate business opportunities and determine the most attractive way to maximize their potential.

Her broad based experience includes closing over 30 value creating technology and product licenses for Pfizer Consumer Healthcare, divesting 60 non-strategic pan-European brands, managing a significant alliance with a large Japanese device company for Bayer Diabetes Care, leading the global Open Innovation initiative at GlaxoSmithKline Consumer Healthcare, and completing several M&A transactions for Perrigo Company, the largest generic OTC drug manufacturer.

Jo is a CPA and holds a BBA and MBA in Accounting from the University of Texas.